|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Mar 24, 2021 |
Title |
oocyte 63 |
Sample type |
SRA |
|
|
Source name |
S39-2
|
Organism |
Homo sapiens |
Characteristics |
cell type: oocyte ID: S39 maturation stage: MII
|
Treatment protocol |
Women were stimulated with highly purified urinary hMG (Menopur®, Ferring, Spain) or follitropin alpha (Gonal®, Merck-Serono, Spain), with daily injections of 150-300 IU (Blazquez et al., 2014). A GnRH antagonist (0.25 mg of Cetrorelix acetate, Cetrotide®, Merck Serono, Spain) was administered daily from day 6 of stimulation (for donors) or from when a follicle of 14 mm or estradiol ≥ 400 pg/ml was detected (for patients) (Olivennes et al., 1996). In the case of donors, when 3 or more follicles of >18 mm of diameter were observed, final oocyte maturation was triggered with 0.2 mg of triptorelin (Decapeptyl®, Ipsen Pharma, Spain). In the case of patients, when 3 follicles of >17 mm of diameter were observed, final oocyte maturation was triggered with 250 µg of alpha-choriogonadotropin (Ovitrelle®, MERCK) or 0.3 mg of triptorelin (Decapeptyl®, Ipsen Pharma, Spain).
|
Growth protocol |
NA
|
Extracted molecule |
total RNA |
Extraction protocol |
Oocyte retrieval was performed 36h later by ultrasound-guided transvaginal follicular aspiration. Oocytes were denuded 30 minutes after pick-up by exposure to 80 IU/ml hyaluronidase (Hyase-10x, Vitrolife, Sweden) in G-MOPS medium (Vitrolife, Sweden), followed by gentle pipetting. Once denuded, oocytes were scored for polar body presence and immature GV were either processed immediately as GV or further cultured in vitro in 50 μl of G2-PLUS (Vitrolife, Sweden) medium in a humidified atmosphere of 6%CO2/94% at 37ºC for 30 hours, when they were checked again for polar body presence and processed. Full-length single-cell RNA-seq libraries were prepared using the Smart-seq2 protocol (Picelli et al., 2013) with minor modifications. Briefly, oocytes were dezoned with Pronase (Roche Diagnostics, Spain), and individually placed in 2.3 µl of a lysis buffer containing 0.2% Triton-X100 (T8787, Sigma) and 1 U/µl RNAse inhibitor (N8080119, Applied Biosystem), and stored at -80ºC until use. Reverse transcription was performed using SuperScript II (ThermoFisher Scientific) in the presence of 1 μM oligo-dT30VN (IDT), 1 μM template-switching oligonucleotides (QIAGEN), and 1 M betaine. cDNA was amplified using the KAPA Hifi Hotstart ReadyMix (Kapa Biosystems) and IS PCR primer (IDT), with 20 cycles of amplification. Following purification with Agencourt Ampure XP beads (Beckmann Coulter), product size distribution and quantity were assessed on a Bioanalyzer using a High Sensitivity DNA Kit (Agilent Technologies). A total of 140 pg of the amplified cDNA was fragmented using Nextera XT (Illumina) and amplified with Nextera XT indexes (Illumina). Products of each of the 96-well plate were pooled and purified twice with Agencourt Ampure XP beads (Beckmann Coulter). Final libraries were quantified and checked for fragment size distribution using a Bioanalyzer High Sensitivity DNA Kit (Agilent Technologies). Pooled sequencing of Nextera libraries was carried out using a HiSeq4000 (Illumina) to an average sequencing depth of >1 million reads per cell. Sequencing was carried out as paired-end (PE75) reads with library indexes corresponding to cell barcodes (Unique dual indexing).
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 4000 |
|
|
Data processing |
Primary data analysis and QC assessment was carried out with the standard Illumina pipeline following the manufacturer's protocol Smart-seq2 libraries were mapped as paired-end reads using STAR 2.5.4b and RSEM 1.3.0 for the quantification Genome_build: GRCh38 Supplementary_files_format_and_content: Tab-separated values (TSV) files containing gene expression values as raw counts
|
|
|
Submission date |
Sep 30, 2020 |
Last update date |
Mar 24, 2021 |
Contact name |
Paula Nieto |
E-mail(s) |
[email protected]
|
Organization name |
CNAG
|
Department |
CNAG
|
Lab |
Single-Cell Genomics
|
Street address |
Barcelona, Barcelona Science Park - Tower I
|
City |
Barcelona |
State/province |
Spain |
ZIP/Postal code |
08028 |
Country |
Spain |
|
|
Platform ID |
GPL20301 |
Series (1) |
GSE158802 |
Impact of maternal age and in vitro maturation on the transcriptome of denuded human oocytes |
|
Relations |
BioSample |
SAMN16302912 |
SRA |
SRX9219145 |
Supplementary data files not provided |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|